Summary
Invesco Pharmaceuticals ETF is an ETF - a fund traded on an exchange like a stock - run by Invesco. Positions inside: 33. The ten largest make up 51% of the fund.
- Yearly costs
- 0.58%
- Fund size
- $550.5M
- Positions
- 33
- Dividend yield
- 0.91%
- Running since
- 2005
What speaks for it
- Average yearly growth over the last ten years: 7.6%.
- It has been running since 2005.
What to watch
- The ten largest positions make up 51% of the fund, so its result rests on a few names.
- 100% of the fund is in one sector (Healthcare).
- 97% of the fund is in one country (United States).
- Costs of 0.58% a year are above the middle of comparable funds (0.44%).
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- -1.4%
- 3 months
- +4.8%
- This year
- +18%
- 1 year
- +30%
- 3 years
- +75%
- 5 years
- +58%
- 10 years
- +109%
- Avg. market cap
- $199.9B
- P/E
- 22.2x
- Forward P/E
- 13.7x
- P/S
- 3.0x
- P/B
- 3.3x
- P/FCF
- 14.7x
- EV/EBITDA
- 11.4x
- Dividend yield
- 1.60%
- ROIC
- 7.8%
- ROE
- 16.8%
- Gross margin
- 72.2%
- Operating margin
- 7.2%
- Net margin
- 1.4%
- Payout ratio
- 35.5%
- Net debt/EBITDA
- 13.0x
- Beta
- 0.44
Weighted average of the 27 largest companies, which make up 100% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Concentrated- 1 ABAbbVie ABBV 5.9%
- 2 GIGilead Sciences GILD 5.9%
- 3 PFPfizer PFE 5.7%
- 4 LLEli Lilly LLY 5.6%
- 5 AMAmgen AMGN 5.4%
- 6 MRMerck & Co. MRK 5.1%
- 7 JNJohnson & Johnson JNJ 5.1%
- 8 ABAbbott Laboratories ABT 5.0%
- 9 PRPerrigo PRGO 3.6%
- 10 VTViatris VTRS 3.4%
Positions in the fund: 33. The ten largest make up 51% of it.
Composition as of Oct 17, 2026.
Where is it spread?
One sector dominatesBy sector
- Healthcare 100%
By country
- United States 97%
- Ireland 2.6%
By company size
- Mega cap 27%
- Large cap 38%
- Mid cap 24%
- Small cap 11%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.
Largest sector: Healthcare (100%). Largest country: United States (97%). Largest size group: Large cap (38%).
What does it cost me?
Expensive- A year from $10,000
- $58.00
- Over 20 years
- $2,782
From every $10,000 invested the fund takes $58.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $2,782.
How has it done?
Growing over the long run- A year on average, 10 years
- +7.6%
- Deepest drop
- -19%
- Yearly volatility
- 17%
Average yearly growth over the last ten years: 7.6%. Deepest drop in these years: 19% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 0.91%
- Payments a year
- 4
- Last payment
- $0.30
Over the last 12 months it paid $1.13 per share, which is 0.91% of today's price. The last payment was $0.30 on Sep 21, 2026.
Is it easy to buy and sell?
Yes- Traded a day
- $4.69M
- Shares a day
- 38K
On an average day about $4.69M of the fund changes hands.
How expensive are the companies inside?
Usual valuation- P/E of the companies inside
- 22.2
- Average Bulios Score
- 56 out of 100
Weight by Bulios Fair Price
- Undervalued 37%
- Fairly valued 16%
- Overvalued 47%
On average the companies inside trade for 22.2 times their yearly profit. By Fair Price, 47% of the rated weight comes out as overvalued.
Counted from its largest companies (27), which make up 100% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.
Similar funds
Funds that hold much of the same. The overlap says how much of their weight they share with this fund.
| Fund | Domicile | Size | 1-year change | Dividends | ||
|---|---|---|---|---|---|---|
FT FTXH First Trust Nasdaq Pharmaceuticals ETF | United States | 0.60% | $1.11B | +41% | Pays out | 55% |
LM LMAX.TO Hamilton Healthcare YIELD MAXIMIZER ETF | Canada | 0.65% | $174.4M | +1.5% | Pays out | 46% |
LI LIFE.TO Evolve Global Healthcare Enhanced Yield Fund | Canada | 0.45% | $253.3M | -4.6% | Pays out | 44% |
ME MEDX Horizon Kinetics Medical ETF | United States | 0.85% | $16.9M | +12% | Pays out | 39% |
IY IYH iShares U.S. Healthcare ETF | United States | 0.37% | $4.33B | +21% | Pays out | 38% |
ZP ZPDH.DE State Street SPDR S&P U.S. Health Care Select Sector UCITS ETF (Acc) | Ireland | 0.15% | $619.4M | +28% | Reinvests | 38% |